Chlamydia and non-gonococcal urethritis

Current Opinion in Infectious Diseases

Volumn 10, Issue 1, 1997, Pages 44-49

  Hay, P E ^a   Ghaem Maghami, S ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; TETRACYCLINE;

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL FEATURE; ECTOPIC PREGNANCY; FEMALE; HUMAN; IMMUNOPATHOLOGY; MALE; MYCOPLASMA; NEISSERIA GONORRHOEAE; NONHUMAN; SHORT SURVEY; TRICHOMONAS VAGINALIS; UREAPLASMA UREALYTICUM; URETHRITIS; UTERINE TUBE OCCLUSION;

EID: 0030960770     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199702000-00011     Document Type: Short Survey

References (63)

1. Herrmann B, Egger M: Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985-1993: declining rates for how much longer? Sex Trans Dis 1995, 22:253-260.
2. Hillis S, Black C, Newhall J, Walsh C, Groseclose SL: New opportunities for chlamydia prevention: applications of science to public health practice. Sex Trans. Dis. 1995, 22:196-202.
3. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, Mayaud P, Changalucha J, Nicoll A, ka-Gina G, Newell JU, Mugeye K, Mabey D, Hayes R: Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995, 346:530-536. A milestone study which demonstrates the effectiveness of STD control in reducing the burden of HIV infection in Africa.
4. Whitaker L, Renton A: Impact of improved treatment of sexually transmitted disease on HIV infection. Lancet 1995, 34:1158-1159.
5. Dik J, Habbema F, de Vlas SJ: Impact of improved treatment of sexually transmitted disease on HIV infection. Lancet 1995, 34:1157-1158.
6. Rygnestad T, Smabrekke L, Nesje L, Talsethagen H, Rogne P, Myhr K, Bentzen I: Impact of improved treatment of sexually transmitted disease on HIV infection. Lancet 1995, 34:1157.
7. Grosskurth H, Mayaud P, Mosha F, Todd J, Senkoro K, Newell J, Gabone R, Changalucha J, West B, Hayes R, Mabey D: Asymptomatic gonorrhoea and chlamydial infection in rural Tanzanian men. BMJ 1996, 312:277-280.
8. Lyons JM, Ito Jr JI: Reducing the risk of C. trachomatis genital tract infection by evaluating the prophylactic potential of vaginally applied chemicals. Clin Infect Dis 1995, 21(suppl):S174-S177.
9. Mahmoud EA, Svensson LO, Olsson SE, Mardh PA: Antichlamydial activity of vaginal secretion. Am J Obstet Gynecol 1995, 172:1268-1272.
10. Taylor-Robinson D: The history of non-gonococcal urethritis. Sex Trans Dis 1996, 23:86-91. A thorough and rigorous review of the history of non-gonococcal urethritis.
11. Jensen JS, Hansen HT, Lind K: Isolation of Mycoplasme genitalium strains from the male urethra. J Clin Microbiol 1996, 34:286-291.
12. Janier M, Lassau F, Casin I, Grillot P, Scleux C, Zavaro A, Chastang C, Blanchi A, Morel P: Male urethritis with and without discharge: a clinical and microbiological study. Sex Transm Dis 1995, 22:244-252. A thought-provoking study of the aetiology and diagnosis of non-gonococcal urethritis.
13. Borchardt KA, al-Haraci S, Maida N: Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch TV test. Genitourin Med 1995; 71:405-406.
14. Swenson PD, Lowens MS, Celum CL, Hierholzer JC: Adenovirus types 2, 8, and 37 associated with genital infections in patients attending a sexually transmitted disease clinic. J Clin Microbiol 1995, 33:2728-2731.
15. Wassen L, Schonk K, Holmgren J, Jertborn M, Lycke N: Local vaccination of the female genital tract is efficient. Clin Immunol Immunopathol 1995, 76:844.
16. Gallichan WS, Rosenthal KL: Specific secretory immune responses in the female genital tract following intranasal immunisation. Vaccine 1995, 13:1589-1595.
17. Vaahloranta LH, Lehtonen OP, Forsten Y, Meurman OH, Saari KM: Tear anti-Chlamydia antibodies in males with chlamydial urethritis. Ophthal Res 1993, 25:23-29.
18. Kätteh WH, Mestecky J: Secretory immunity in the female reproductive tract. Am J Reprod Immunol 1994, 31:40-46.
19. Czerkinsky C, Svennerholm AM, Holmgren J: Induction and assessment of immunity at enteromucosal surfaces in humans. Clin Infect Dis 1993, 16(suppl 2):106-116.
20. Brunham RC, Kuo CC, Cles L, Holme KK: Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun 1983, 39:1491-1494.
21. Bailey R, Kajbaf M, Whittle HC, Ward ME, Mabey DCW: The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective. Epidemiol Infect 1993, 111:315-324.
22. Morrison RP, Feilzer K, Tumas DB: Gene knock out mice establish a primary protective role for major histocompatibility complex II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 1995, 63:1784-1789.
23. Magee DM, Williams DM, Smith JG, Bleicker CA, Grubbs BG, Schachter J, Rank RG: Role of CD8 T cells in primary chlamydia infection. Infect Immun 1995, 63:516-521.
24. Ramsey KH, Rank RG: Resolution of chlamydial genital infection with antigen specific T cell lines. Infect Immun 1991, 59:925-931.
25. H2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 1996, 105:429-435.
26. Bobo L, Novak N, Mcocha H, Vitale S, West S, Quinn T: Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect Immun 1996, 64:3273-3279.
27. VanCott JL, Pascual DW, Chatfiled SN, McGhee J: The host response to mucosal vaccines in the context of targeted gene knockout mice. Mucos Immunol Update 1995, 3:3-14.
28. + T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun 1995, 63:3301-3308.
29. Meslecky J: The common mucosal immune system and current strategies for induction of immune responses is external secretions. J Clin Immunol 1987, 7:265-276.
30. Apicella A, Blake M, Byrne G: Vaccines for sexually transmitted diseases. Curr Opin Infect Dis 1996, 9:52-55.
31. Johnson A: Pathogenesis and immunity of chlamydial infections of the genital tract. Rev Infect Dis 1985, 7:741-745.
32. Czerkinsky C, Svennerholm AM, Holmgren J: Induction and assessment of immunity at enteromucosal surfaces in humans. Clin Infect Dis 1993,16(suppl 2):106-116.
33. Su H, Parnell M, Caldwell H: Protective efficacy of a parenterally adminstered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralising IgG antibodies do not protect against chlamydial genital tract infection. Vaccine 1995, 13:1023-1032.
34. van Doornum GJ, Buimer M, Prins M, Henquet CJ, Coutinho RA, Plier PK, Tomazic-Allen S, Hu H, Lee H: Detection of Chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction. J Clin Microbiol 1995, 33:2042-2047.
35. Schachter J, Moncada J, Whidden R, Shaw H, Bolan G, Burczak JD, Lee HH: Noninvasive tests for diagnosis of Chlamydia trachomatis infection: application of ligase chain reaction to first-catch urine specimens of women. J Infect Dis 1995, 172:1411-1414.
36. Lee HH, Chernesky MA, Schachter J, Burczak JD, Andrews WW, Muldoon S, Leckie G: Stamm WE: Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995, 345:213-216.
37. Bassin M, Hu HY, Domeika MA, Burczak J, Svensson LO, Lee HH, Mardh PA: Detection of Chlamydia trachomatis in urine specimens from women by ligase chain reaction. J Clin Microbiol 1995, 33:898-900.
38. Hadgu A: The discrepancy in discrepant analysis. Lancet 1996, 348:592-593.
39. de Barbeyrac B, Rodriguez P, Dutilh B, Le Roux P, Bebear C: Detection of C. trachomatis by ligase chain reaction compared with polymerase chain reaction and cell culture in urogenital specimens. Genitourin Med 1995 71:382-384.
40. Kuipers JG, Scharmann K, Wollenhaupt J, Nettelnbreker E, Hopf S, Zeidler H: Sensitivities of PCR, MicroTrak, ChlamydiaEIA, IDEIA, and PACE 2 for purified Chlamydia trachomatis elementary bodies in urine, peripheral blood, peripheral blood leukocytes, and synovial fluid. J Clin Microbiol 1995, 33:3186-3190.
41. Mahony JB, Luinstra KE, Tyndall M, Sellers JW, Krepel J, Chernesky M: Multiplex PCR for detection of Chlamydia trachomatis and Neisseria gonorrhoeas in genitourinary specimens. J Clin Microbiol 1995; 33:3049-3053.
42. Iwen PC, Walker RA, Warren KL, Kelly DM, Hinrichs SH, Linder J: Evaluation of nucleic acid-based test (PACE 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens. J Clin. Biol 1995, 33:2587-2591.
43. Anestad G, Berdal BP, Scheel O, Mundal R, Odinsen O, Skaug K, Khalil OS, Plier P, Lee H: Screening urine samples by leukocyte esterase test and ligase chain reaction for chlamydial infections among asymptomatic men. J Clin Microbiol 1995, 33:2483-2484.
44. White DJ, Malet RM, Bignell CJ: Non-invasive sampling method for detecting C. trachomatis. Lancet 1989, i:96-97.
45. Patrick DM, Rekart ML, Knowles L: Unsatifactory performance of the leukocyte esterase test of first voided urine for rapid diagnosis of urethritis. Genitourin Med 1994, 70:187-189.
46. Fraser PA, Teasdale J, Can KS, Eglin R, Scott SC, Lacey CJ: Neutrophil enzymes in urine for the detection of urethral infection in men. Genitourin Med 1995, 71:176-179.
47. Leonardi GP, Stavroulakis AM, Cruz J, Szabo K: Evaluation of verification assays in EIA specimens presumptively positive for Chlamydia trachomatis. J Med Microbiol 1996, 44:147-150.
48. Ostergaard L, Moller JK: Use of PCR and direct immunofluorescence microscopy for confirmation of results obtained by Syva MicroTrak Chlamydia enzyme immunoassay. J Clin Microbiol 1995, 33:2620-2623.
49. Ezazi S, Ezazi S, Aavitsland P: False positive tests of sexually transmitted Chlamydia trachomatis infections. [Norwegian] oiginal title: Falskt positive prover for seksuelt overfort infeksjon med Chlamydia trachomatis. Tidsskr Norske Laegeforen 1995, 115:3145-3147.
50. Kellog JA: Impact of variation in endocervical specimen collection and testing techniques on frequency of false-positive and false-negative chlamydia detection results. Am J Clin Pathol 1995, 104:554-559. A good reminder of the importance of adequate swab-taking.
51. Kellogg JA, Seiple JW, Klinedinst JL, Stroll ES, Cavanaugh SH: Improved PCR detection of Chlamydia trachomatis by using an altered method of specimen transport and high-quality endocervical specimens. J Clin Microbiol 1995, 33:2765-2767.
52. Majid D, Douglas Jr JM, Schwartz JS: Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Int Med 1996, 124:389-399.
53. Haddix AC, Hillis SD, Kassler WJ: The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women. Sex Trans Dis 1995, 22:274-280.
54. Genk M, Mardh A: A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996, 124:1-7.
55. Turrentine MA, Newton ER: Amoxicillin or erythromycin for the treatment of antenatal chlamydial infection: a meta-analysis. Obstet Gynecol 1995, 86:1021-1025.
56. Carlin EM, Barton SE: How common is self-treatment in non-gonococcal urethritis? Genitourin Med 1995, 71:400-401.
57. Wølner-Hanssen P. Silent pelvic inflammatory disease: is it overstated? Obstet Gynecol 1995, 86:321-325. A well-designed prospective study stressing the importance of taking a thorough history.
58. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE: Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996, 334:1362-1366. This study presents good evidence that screening for chlamydia does prevent the subsequent development of PID.
59. Gencay M, Koskiniemi M, Saikku P, Puolakkainen M, Raivio K, Koskela P, Vaheri A: Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications. Clin Infect Dis 1995; 21:424-426.
60. Osser S, Persson K: Chlamydial antibodies in women who suffer miscarriage. Br J Obstet Gynaecol 1996, 103:137-141.
61. Beutler AM, Schumacher Jr HR, Whittum-Hudson JA, Salameh WA, Hudson AP: Case report: in situ hybridization for detection of inapparent infection with Chlamydia trachomatis in synovial tissue of a patient with Reiter's syndrome. Am J Med Sci 1995, 310:206-213.
62. Nanagara R, Li F, Beutler A, Hudson A, Schumacher Jr HR: Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthr Rheum 1995, 381:1410-1417.
63. Genereau T, Wechsler B, Frances C, Godeau P: Cutaneous vasculitis during Chlamydia trachomatis seroconversion. Br J Dermatol 1995, 132:1022-1023.